RecruitingPhase I/IIEN original

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ponatinib in children aged 1 to \< 18 years with advanced leukemias, lymphomas, and solid tumors.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Potwierdzona diagnoza białaczki (CML, ALL, AML), chłoniaka lub guza litego
  • Wiek od 1 roku do poniżej 18 lat
  • Rak, który nie reaguje na wcześniejsze leczenie lub standard nie jest dostępny
  • W przypadku białaczki CML: oporność na co najmniej jeden poprzedni lek lub mutacja T315I
  • Wynik badania szpiku kostnego potwierdzający rodzaj raka (wykonany w ciągu 42 dni przed rozpoczęciem leczenia)
  • Guz można zmierzyć za pomocą badań obrazowych (CT lub MRI)

Simplified criteria — AI translation

Trial details

Minimum age
1 Year
Maximum age
17 Years
Last updated (source)
July 23, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (23)

Ghent University Hospital

Ghent, Belgium

Hopital Robert Debre

Paris, France

Armand Trousseau Hospital

Paris, France

Centre Hospitalier Universitaire de Poitiers

Poitiers, France

Chu de Rennes - Hospital Sud

Rennes, France

Aou Policlinico S. Orsola-Malpighi

Bologna, Italy

Asst Degli Spedali Civili Di Brescia

Brescia, Italy

Ospedale Pediatrico G. Gaslini

Genova, Italy

Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano

Milan, Italy

University of Milano Bicocca

Monza, Italy

Aorn Santobono Pausilipon

Naples, Italy

Comitato Di Bioetica Della Fondazione Irccs Policlinico San Matteo

Pavia, Italy

Ospedale Pediatrico Bambino Gesu Irccs

Rome, Italy

A.O.U Citta Della Salute E Della Scienza Di Torino Presidio Ospedaliero Infantile Regina Margherita

Torino, Italy

Princess Maxima Center For Pediatric Oncology

Utrecht, Netherlands

Hospital General Universitario Vall D Hebron

Barcelona, Spain

Hospital Sant Joan de Deu de Manresa

Barcelona, Spain

Hospital Infantil Unversitario Nino Jesus

Madrid, Spain

Hospital Universitari I Politecnic La Fe

Valencia, Spain

Karolinska University Hospital Solna

Stockholm, Sweden

Royal Hospital For Sick Children Yorkhill Glasgow

Glasgow, United Kingdom

Alder Hey Childrens Nhs Foundation Trust

Liverpool, United Kingdom

The Royal Marsden Nhs Foundation Trust - Sutton

Sutton, United Kingdom

Trial contact

Incyte Corporation Call Center (ex-US)

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/9/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.